Summary.
A G309D mutation in the PINK1 gene in a consanguineous Spanish kindred with seven siblings, three of whom are clinically affected, has recently been shown to be a cause of the PARK6 form of autosomal-recessive Parkinson’s syndrome. In this family, we studied pre- and postsynaptic dopaminergic function using 123I-FP-CIT- and 123I-iodobenzamide-SPECT to determine binding to the presynaptic dopamine transporter (DAT) and postsynaptic D2 receptors respectively.
All three PARK6 patients showed reduced striatal DAT binding with posterior preponderance similar to sporadic idiopathic PD, but only one patient showed significant striatal asymmetry. In two of the siblings, DAT binding was markedly increased. IBZM-SPECT was normal in both patients and sibs.
Our findings indicate that 123I-FP-CIT-SPECT shows similar DAT binding in PARK6 patients compared to idiopathic Parkinson’s disease. The increased DAT binding in heterozygous PARK6 carriers may be a new very early preclinical finding, but its significance is still unclear.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A Antonini J Schwarz WH Oertel O Pogarell KL Leenders (1997) ArticleTitleLong-term changes of striatal dopamine D2 receptors in patients with Parkinson’s disease: a study with positron emission tomography and [11C]raclopride. Mov Disord 12 33–38 Occurrence Handle10.1002/mds.870120107 Occurrence Handle8990051
MF Beal (2003) ArticleTitleMitochondria, oxidative damage, and inflammation in Parkinson’s disease. Ann NY Acad Sci 991 120–131 Occurrence Handle12846981
HTS Benamer J Patterson DG Grosset (2000) ArticleTitleAccurate differentiation of parkinsonian and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 13 503–510 Occurrence Handle10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V
R Benecke P Strumper H Weiss (1993) ArticleTitleElectron transfer complexes I and IV of platelets are abnormal in Parkinson’s disease but normal in Parkinson-plus syndromes. Brain 116 1451–1463 Occurrence Handle8293280
AR Bentivoglio P Cortelli EM Valente T Ialongo A Ferraris A Elia P Montagna A Albanese (2001) ArticleTitlePhenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families. Mov Disord 16 999–1006 Occurrence Handle10.1002/mds.10034 Occurrence Handle11748730
H Bernheimer W Birkmayer O Hornykiewicz K Jellinger F Seitelberger (1973) ArticleTitleBrain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20 415–455 Occurrence Handle10.1016/0022-510X(73)90175-5 Occurrence Handle4272516
KA Cheon YH Ryu YK Kim K Namkoong CH Kim JD Lee (2003) ArticleTitleDopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging 30 306–311 Occurrence Handle12552351
KA Cheon YH Ryu K Namkoong CH Kim JJ Kim JD Lee (2004) ArticleTitleDopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette’s disorder. Psychiatry Res 130 85–95 Occurrence Handle14972371
Fahn S, Elton RL (1987) Unified Parkinson’s Disease rating scale. In: Fahn S et al. (eds) Recent development in Parkinson’s disease II. McMillan Healthcare Information, Florham Park (NJ), pp 153–163
P Foley P Riederer (2000) ArticleTitleInfluence of neurotoxins and oxidative stress on the onset and progression of Parkinon’s disease. J Neurol 247 82–94
RR Gainetdinov MG Caron (2003) ArticleTitleMonoamine transporters: from genes to behavior. Ann Rev Pharmacol Toxicol 43 261–284 Occurrence Handle10.1146/annurev.pharmtox.43.050802.112309
R Hilker C Klein M Ghaemi B Kis T Strotmann LJ Ozelius O Lenz P Vieregge K Herholz WD Heiss PP Pramstaller (2001) ArticleTitlePositron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol 49 367–376 Occurrence Handle10.1002/ana.74 Occurrence Handle11261512
P Jenner CW Olanow (1996) ArticleTitleOxidative stress and the pathogenesis of Parkinson’s disease. Neurology 47 161–170
V Kaasinen HM Ruottinen K Nagren P Lehikoinen V Oikonen JO Rinne (2000) ArticleTitleUpregulation of putaminal dopamine D2 receptors in early Parkinson’s disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone. J Nucl Med 41 65–70 Occurrence Handle10647606
NL Khan EM Valente AR Bentivoglio NW Wood A Albanese DJ Brooks P Piccini (2002) ArticleTitleClinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol 52 849–853 Occurrence Handle10.1002/ana.10417 Occurrence Handle12447943
J Lavalaye J Booij L Reneman JBA Habraken EA van Royen (2000) ArticleTitleEffect of age and gender on dopamine transporter imaging with 123I-FP-CIT SPET in healthy volunteers. Eur J Nucl Med Mol Imaging 27 867–869 Occurrence Handle10.1007/s002590000279
SA Oliveira WK Scott ER Martin MA Nance RL Watts JP Hubble WC Koller R Pahwa MB Stern BC Hiner WG Ondo FHJ Allen BL Scott CG Goetz GW Small F Mastaglia JM Stajich F Zhang MW Booze MP Winn LT Middleton JL Haines MA Pericak-Vance JM Vance (2003) ArticleTitleParkin mutations and susceptibility alleles in late-onset Parkinson’s disease. Ann Neurol 53 624–629 Occurrence Handle10.1002/ana.10524 Occurrence Handle12730996
P Piccini PK Morrish N Turjanski GV Sawle DJ Burn RA Weeks MH Mark D Maraganore AJ Lees DJ Brooks (1997) ArticleTitleDopaminergic functions in familial Parkinson’s disease: a clinical and 18F-DOPA positron emission tomography study. Ann Neurol 41 222–229 Occurrence Handle10.1002/ana.410410213 Occurrence Handle9029071
Plotkin M, Amthauer H, Klaffke S, Kühn A, Lüdemann L, Arnold G, Wernecke K-D, Kupsch A, Felix R, Venz S (2004) Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm (DOI 10.1007/200702-004-0208-x; epub ahead of print)
A Samii K Markopoulou ZK Wszolek V Sossi T Dobko E Mak DB Calne AJ Stoessl (1999) ArticleTitlePET studies of parkinsonism associated with mutation in the alpha-synuclein gene. Neurology 53 2097–2102 Occurrence Handle10599788
J Schwarz K Tatsch G Arnold M Ott C Trenkwalder CM Kirsch WH Oertel (1993) ArticleTitle123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Neurology 43 IssueID[Suppl 6] S17–S20 Occurrence Handle8264906
A Sidhu C Wersinger P Vernier (2004) ArticleTitleAlpha-synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson’s disease. FEBS Lett 565 1–5 Occurrence Handle10.1016/j.febslet.2004.03.063 Occurrence Handle15135042
H Sjoholm T Bratlid J Sundsfjord (2004) ArticleTitle123I-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia. Psychopharmacology (Berl) 173 27–31 Occurrence Handle10.1007/s00213-003-1700-y
EM Valente AR Bentivoglio PH Dixon A Ferraris T Ialongo M Frontali A Albanese NW Wood (2001) ArticleTitleLocalization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35–p36. Am J Hum Genet 68 895–900 Occurrence Handle10.1086/319522 Occurrence Handle11254447
EM Valente PM Abou-Sleiman V Caputo MMK Muqit K Harvey S Gispert Z Ali D Del Turco AR Bentivoglio DG Healy A Albanese R Nussbaum R Gonzalez-Maldonado T Deller S Salvi P Cortelli WP Gilks DS Latchman RJ Harvey B Dallapiccola G Auburger NW Wood (2004) ArticleTitleHereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science 304 1158–1160 Occurrence Handle10.1126/science.1096284 Occurrence Handle15087508
EM Valente F Brancati A Ferraris EA Graham MB Davis MM Breteler T Gasser V Bonifati AR Bentivoglio G De Michele A Durr P Cortelli D Wassilowsky BS Harhangi N Rawal V Caputo A Filla G Meco BA Oostra A Brice A Albanese B Dallapiccola NW Wood (2002) ArticleTitlePARK6-linked parkinsonism occurs in several European families. Ann Neurol 51 14–18 Occurrence Handle10.1002/ana.10053 Occurrence Handle11782979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kessler, K., Hamscho, N., Morales, B. et al. Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson’s syndrome. J Neural Transm 112, 1345–1353 (2005). https://doi.org/10.1007/s00702-005-0281-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-005-0281-9